Expression of plasminogen receptors on C6 glioma cells. 1989

S W Hall, and S R VandenBerg, and S L Gonias
Department of Pathology, University of Virginia Health Sciences Center, Charlottesville 22908.

Plasminogen activators (PAs) play an important role in normal and neoplastic neuromorphogenesis in the central nervous system. Proper function of proteinases such as PA may require focusing of activity on a cellular level. In this study, we demonstrate that highly purified plasminogen binds to receptors on rat C6 glioma cells in culture. Specific binding is reversible and saturable at 4 degrees C. The Kd is 1.95 +/- 0.31 microM and the Bmax is 3.6 x 10(6) molecules/cell. At 37 degrees C, there is no evidence for ligand digestion or internalization. Plasminogen receptors may concentrate potential proteinase near membranes of glia during normal and neoplastic development in the central nervous system.

UI MeSH Term Description Entries
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D055293 Receptors, Urokinase Plasminogen Activator An extracellular receptor specific for UROKINASE-TYPE PLASMINOGEN ACTIVATOR. It is attached to the cell membrane via a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE and plays a role in the co-localization of urokinase-type plasminogen activator with PLASMINOGEN. Antigens, CD87,Urokinase Plasminogen Activator Receptor,Urokinase Type Plasminogen Activator Receptor,Urokinase-Type Plasminogen Activator Receptor,CD87 Antigen,Plasminogen Activator Receptor, Urokinase Type,Plasminogen Activator, Urokinase Receptor,Plasminogen Activator, Urokinase Receptors,Receptor, Pro-Urokinase,Receptor, Urokinase Plasminogen Activator,U-PA Receptor,Upar Receptor,Urokinase Plasminogen Activator Receptors,Urokinase-Type Plasminogen Activator Receptors,Antigen, CD87,CD87 Antigens,Pro-Urokinase Receptor,Receptor, Pro Urokinase,Receptor, U-PA,Receptor, Upar,U PA Receptor,Urokinase Type Plasminogen Activator Receptors

Related Publications

S W Hall, and S R VandenBerg, and S L Gonias
August 1987, Neurochemical research,
S W Hall, and S R VandenBerg, and S L Gonias
June 2007, Neurochemical research,
S W Hall, and S R VandenBerg, and S L Gonias
January 2005, Pharmacological reports : PR,
S W Hall, and S R VandenBerg, and S L Gonias
May 1997, European journal of pharmacology,
S W Hall, and S R VandenBerg, and S L Gonias
April 1984, Journal of neurochemistry,
S W Hall, and S R VandenBerg, and S L Gonias
November 2000, The Journal of surgical research,
S W Hall, and S R VandenBerg, and S L Gonias
December 1992, Molecular and cellular neurosciences,
S W Hall, and S R VandenBerg, and S L Gonias
November 2005, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience,
S W Hall, and S R VandenBerg, and S L Gonias
July 1981, The Journal of biological chemistry,
S W Hall, and S R VandenBerg, and S L Gonias
May 1991, The American journal of physiology,
Copied contents to your clipboard!